论文信息 - Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. - 字舞流文

Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.

I. Thompson | D. Ankerst | R. Svatek | M. Liss | D. Kaushik | E. Morales | Sonja Grill | Edwin E. Morales | I. Thompson

[1] Kotaro Suzuki,et al. Androgen deprivation therapy prevents bladder cancer recurrence , 2014, Oncotarget.

[2] Chawnshang Chang,et al. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation. , 2013, Oncology reports.

[3] Xue-Ru Wu,et al. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. , 2013, The American journal of pathology.

[4] S. Xia,et al. Androgen receptor is a potential therapeutic target for bladder cancer. , 2010, Urology.

[5] David Chia,et al. Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[6] Michael M Lieber,et al. The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.